A subset of DCLK1+ cancer stem cells was able to overcome the inhibitory effects of chemotherapeutic agents via an autophagic survival mechanism; loss of DCLK1 combined with the chemotherapeutic/chemopreventive agents was required to achieve the eradication of cancer stem cells and to prevent tumor relapse [427]. Here, DCLK1 is linked to neoplasm.